Notch4 promotes gastric cancer growth through activation of Wnt1/β-catenin signaling

Molecular and Cellular Biochemistry

Volumn 401, Issue 1-2, 2015, Pages 165-174

  Qian, Cuijuan ^a   Liu, Fuqiang ^a   Ye, Bei ^b   Zhang, Xin ^b   Liang, Yong ^a   Yao, Jun ^a  

^a TAIZHOU UNIVERSITY   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Gastric cancer; Growth; Notch; Wnt1; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; NOTCH4 RECEPTOR; SMALL INTERFERING RNA; UVOMORULIN; WNT1 PROTEIN; NOTCH RECEPTOR; NOTCH4 PROTEIN, HUMAN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRDU ASSAY; CANCER GROWTH; CANCER SIZE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MTS ASSAY; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH EPITHELIUM; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; STOMACH TUMOR; TISSUE MICROARRAY; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84925466986     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2304-z     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
2. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23(5):700–713
3. Sehdev A, Catenacci DV (2013) Gastroesophageal cancer: focus on epidemiology, classification, and staging. Discov Med 16(87):103–111
4. Pancewicz J, Nicot C (2011) Current views on the role of Notch signaling and the pathogenesis of human leukemia. BMC Cancer 11:502
5. Nagase H, Nakayama K (2013) γ-Secretase-regulated signaling typified by Notch signaling in the immune system. Curr Stem Cell Res Ther 8(5):341–356
6. Yan M (2011) Therapeutic promise and challenges of targeting DLL4/NOTCH1. Vasc Cell 3:17
7. Klusza S, Deng WM (2011) At the crossroads of differentiation and proliferation: precise control of cell-cycle changes by multiple signaling pathways in Drosophila follicle cells. BioEssays 33(2):124–134
8. Ntziachristos P, Lim JS, Sage J, Aifantis I (2014) From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 25(3):318–334
9. Sasnauskienė A, Jonušienė V, Krikštaponienė A, Butkytė S, Dabkevičienė D, Kanopienė D, Kazbarienė B, Didžiapetrienė J (2014) NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer. Medicina (Kaunas) 50(1):14–18
10. Nagamatsu I, Onishi H, Matsushita S, Kubo M, Kai M, Imaizumi A, Nakano K, Hattori M, Oda Y, Tanaka M, Katano M (2014) NOTCH4 is a potential therapeutic target for triple-negative breast cancer. Anticancer Res 34(1):69–80
11. Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ (2010) Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70(24):10340–10350
12. Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S (2013) Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol 44(11):2438–2448
13. Ju X, Ishikawa TO, Naka K, Ito K, Ito Y, Oshima M (2014) Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Cancer Sci 105(4):418–424
14. Chigita S, Sugiura T, Abe M, Kobayashi Y, Shimoda M, Onoda M, Shirasuna K (2012) CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. Int J Oncol 41(6):2021–2028
15. Koehler A, Schlupf J, Schneider M, Kraft B, Winter C, Kashef J (2013) Loss of Xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. Dev Biol 383(1):132–145
16. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z (2014) EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene 33(21):2737–2747
17. Sun Q, Wang R, Luo J, Wang P, Xiong S, Liu M, Cheng B (2014) Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway. Int J Oncol 45(4):1638–1648
18. Gu B, Watanabe K, Sun P, Fallahi M, Dai X (2013) Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells. Cell Stem Cell 13(1):48–61
19. Li H, Mo J, Jia G, Liu C, Luan Z, Guan Y (2013) Activation of Wnt signaling inhibits the pro-apoptotic role of Notch in gastric cancer cells. Mol Med Rep 7(6):1751–1756
20. Ding LC, She L, Zheng DL, Huang QL, Wang JF, Zheng FF, Lu YG (2010) Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma. Oncol Rep 24(2):363–368
21. Yao W, Li K, Zheng S, Xiao X, Ma Y, Zhai X (2013) Knockdown of β-catenin expression inhibits neuroblastoma cell growth in vitro and in vivo. J Pediatr Surg 48(12):2466–2473
22. Song P, Zheng JX, Liu JZ, Xu J, Wu LY, Liu C, Zhu Q, Wang Y (2014) Effect of the Wnt1/β-catenin signalling pathway on human embryonic pulmonary fibroblasts. Mol Med Rep 10(2):1030–1036
23. Chung HW, Lim JB (2014) Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol 20(7):1667–1680
24. Yang W, Raufi A (1846) Klempner SJ (2014) Targeted therapy for gastric cancer: Molecular pathways and ongoing investigations. Biochim Biophys Acta 1:232–237
25. Lobry C, Oh P, Mansour MR, Look AT, Aifantis I (2014) Notch signaling: switching an oncogene to a tumor suppressor. Blood 123(16):2451–2459
26. Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ (2010) Dysregulation of cellular signaling in gastric cancer. Cancer Lett 295(2):144–153
27. Soutto M, Peng D, Katsha A, Chen Z, Piazuelo MB, Washington MK, Belkhiri A, Correa P, El-Rifai W (2014) Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut pii. doi:10.1136/gutjnl-2014-307191
28. Casás-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, Scarborough HA, Bunn PA Jr, Chan DC, Tan AC, DeGregori J (2012) Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition. Cancer Res 72(16):4154–4164
29. Wang A, Wang J, Ren H, Yang F, Sun L, Diao K, Zhao Z, Song M, Cui Z, Wang E, Wei M, Mi X (2014) TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus. Mol Cell Biochem 395(1–2):211–219
30. Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13(12):767–779
31. Baryawno N, Sveinbjörnsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI (2010) Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res 70(1):266–276
32. Naylor RW, Jones EA (2009) Notch activates Wnt-4 signalling to control medio-lateral patterning of the pronephros. Development 136(21):3585–3595
33. Bhatt T, Rizvi A, Batta SP, Kataria S, Jamora C (2013) Signaling and mechanical roles of E-cadherin. Cell Commun Adhes 20(6):189–199
34. Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q (2013) Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep 29(4):1579–1587
35. Zeljko M, Pecina-Slaus N, Martic TN, Kusec V, Beros V, Tomas D (2011) Molecular alterations of E-cadherin and beta-catenin in brain metastases. Front Biosci (Elite Ed) 3:616–624
36. Mao J, Fan S, Ma W, Fan P, Wang B, Zhang J, Wang H, Tang B, Zhang Q, Yu X, Wang L, Song B, Li L (2014) Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis 5:e1039
37. Qiu HB, Zhang LY, Ren C, Zeng ZL, Wu WJ, Luo HY, Zhou ZW, Xu RH (2013) Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling. PLoS ONE 8(3):e56959